PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2122871
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2122871
According to Mordor Intelligence, the Europe functional beverage market size was valued at USD 33.30 billion in 2025 and is estimated to grow from USD 34.91 billion in 2026 to reach USD 47.12 billion by 2031, at a CAGR of 6.18% during the forecast period (2026-2031).

This report is Segmented by Product Type (Energy Drinks, Sports Drinks, and More), Functionality (Digestive Health, Immune Support, and More), Packaging Type (PET/Glass Bottles, Cans, and More), Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, and More), and Geography (United Kingdom, Germany, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Liters).
European consumers are increasingly incorporating functional beverages into their daily routines as preventive health measures rather than using them as reactive remedies. This behavioral shift, which gained momentum during the COVID-19 pandemic, has now become well-established. A recent survey by the International Probiotics Association Europe revealed that over half of European consumers feel inadequately informed about the health benefits of probiotics. However, nearly half of respondents in the United Kingdom reported consuming a functional beverage within the past three months, highlighting latent demand that could be unlocked through education and clinical validation . This proactive approach is particularly evident in Germany and the Netherlands, where consumers actively seek products enriched with vitamins D and K2 for bone health, omega-3 fatty acids for cardiovascular support, and adaptogens like ashwagandha for stress management. This trend is influencing product development cycles, with brands increasingly allocating research budgets to randomized controlled trials. These trials aim to meet the European Food Safety Authority's cause-and-effect standards for health claims, enabling the transformation of wellness aspirations into regulatory-compliant marketing strategies.
The demand for clean-label products has evolved from a marketing trend to an essential product attribute, as European consumers increasingly examine ingredient lists for artificial sweeteners, synthetic colors, and unfamiliar additives. Natural sweeteners like stevia, derived from *Stevia rebaudiana*, and monk fruit, sourced from *Siraitia grosvenorii*, are replacing aspartame and sucralose in product reformulations. However, manufacturers face challenges in masking the taste of these sweeteners, often requiring co-formulation with erythritol or allulose to achieve acceptable palatability. In February 2024, Danone announced an investment in a new Alpro plant-based facility in France, with a production capacity exceeding 300,000 liters per day, highlighting the scale needed to meet clean-label demand while remaining cost-competitive. Additionally, the Union of European Soft Drinks Associations has pledged a 10% reduction in sugar content across member portfolios by 2025. This commitment has accelerated the adoption of natural flavor systems derived from botanicals such as hibiscus, elderflower, and turmeric. This trend is particularly significant in Germany and France, where organic certification and Nutri-Score labeling strongly influence consumer purchasing decisions at the point of sale.
The European Food Safety Authority (EFSA) enforces rigorous standards for validating health claims, requiring clinical trials that can cost significant amounts per ingredient. These requirements create challenges for small and mid-sized enterprises that lack the necessary research infrastructure. EFSA mandates evidence of cause-and-effect relationships through human randomized controlled trials, a standard that has left thousands of botanical health claims "on hold" for years. This has significantly stifled innovation in the herbal and traditional ingredient categories. European Union Regulation 2024/2105, which rejected health claims for certain probiotic strains and plant extracts, highlights the regulatory conservatism that compels brands to rely on general function claims instead of specific therapeutic messaging . This approach reduces product differentiation and complicates consumer education. The impact of these restrictions is particularly pronounced in Germany and France, where national authorities strictly adhere to EFSA guidelines with minimal flexibility. In contrast, Italy and Spain have historically adopted more lenient interpretations for traditional Mediterranean botanicals, such as olive leaf extract and pomegranate. For instance, in some cases, the approval rate for health claims in these countries has been higher than in others, exceeding 50% for certain traditional ingredients.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Sports Drinks are projected to grow at a compound annual growth rate (CAGR) of 8.23% through 2031, marking the fastest growth among product types. This trend is driven by increasing consumer focus on hydration and electrolyte replenishment, reflecting the rising participation in endurance sports and functional fitness activities across Europe. Energy Drinks accounted for 49.21% of the market in 2025, supported by Red Bull's strong brand presence and Monster's extensive retail partnerships. However, the category faces challenges from age-restriction policies in Eastern Europe and growing concerns about excessive caffeine consumption among adolescents. Fortified Juice is experiencing stagnation as consumers increasingly view traditional orange and apple juice bases as high in sugar. In response, brands are shifting toward cold-pressed, low-glycemic formulations featuring superfruits such as acai, goji, and aronia.
Dairy and Dairy-Alternative Drinks are benefiting from the plant-based trend, with oat and almond bases allowing for fortification with calcium, vitamin D, and omega-3 fatty acids while maintaining vegan-friendly positioning. Functional and Fortified Water is gaining traction among health-conscious urban consumers seeking hydration with added vitamins, minerals, or electrolytes, without the calorie content of traditional sports drinks. In this segment, Vitamin Well has established a strong presence in Sweden and is expanding into Germany and the United Kingdom. The demand for these products is growing as consumers increasingly prioritize health and wellness, with fortified water offering a balance of functionality and low-calorie content.
Digestive Health is projected to be the fastest-growing functionality, with a compound annual growth rate (CAGR) of 8.43% through 2031. This growth is driven by increasing clinical evidence linking gut microbiome diversity to metabolic health, mental well-being, and immune resilience. This shift has elevated probiotics and prebiotics from niche supplements to widely used beverage ingredients. Immune Support accounted for 48.01% of the market in 2025, supported by heightened consumer awareness following the COVID-19 pandemic and the widespread inclusion of vitamin C, zinc, and elderberry in fortified beverages. However, the category faces challenges such as commoditization due to converging efficacy claims and intensifying price competition. Bone and Joint Health, while a smaller segment, is gaining momentum among aging populations in Germany, Italy, and France. Beverages fortified with calcium, vitamin K2 (menaquinone), and collagen peptides are addressing concerns related to osteoporosis and arthritis in these markets. Other Functionalities, including energy, cognitive performance, and beauty-from-within, are diversifying consumer preferences, complicating retail assortment strategies.
The European probiotic market, as reported by the International Probiotics Association Europe, is dominated by fermented dairy drinks such as Danone's Actimel and Yakult . However, innovation is increasingly focused on next-generation postbiotics and psychobiotics. Postbiotics, which consist of non-viable microbial cells or their metabolites, offer advantages such as eliminating the need for cold-chain logistics and addressing issues related to the viability of live probiotic formulations. These features enable the development of shelf-stable products, reducing distribution costs and creating new market opportunities. Furthermore, significant research is being conducted on the gut-brain axis, with early-stage clinical trials exploring the potential of Lactobacillus and Bifidobacterium strains to influence serotonin production and alleviate anxiety. These advancements could transform the Digestive Health market, positioning it as a mental wellness category rather than being confined to gastrointestinal health.